Earnings Report | 2026-05-24 | Quality Score: 92/100
Earnings Highlights
EPS Actual
-0.87
EPS Estimate
-0.33
Revenue Actual
Revenue Estimate
***
structural analysis We focus on delivering actionable insights from earnings reports, technical indicators, and institutional trading activity across major stock market sectors. My Size Inc. (MYSZ) reported Q4 2025 earnings per share (EPS) of -$0.87, significantly below the consensus estimate of -$0.3264, resulting in a negative surprise of -166.54%. The company did not report any revenue for the quarter, with both actual and estimated revenue listed as none. Despite the earnings miss, the stock rose 1.03% in after-hours trading.
Management Commentary
MYSZ -structural analysis Some investors prioritize clarity over quantity. While abundant data is useful, overwhelming dashboards may hinder quick decision-making. Historical trends often serve as a baseline for evaluating current market conditions. Traders may identify recurring patterns that, when combined with live updates, suggest likely scenarios. My Size Inc., a technology company specializing in sizing and measurement solutions, delivered Q4 2025 results that reflected ongoing operational challenges. The reported EPS of -$0.87 implies that operating expenses exceeded the prior quarter’s run-rate and analyst expectations, though the exact drivers remain under review. With no revenue reported, the company appears to still be in a pre-revenue or early-stage commercialization phase, where spending on R&D, sales, and general administration may continue to outpace any limited revenue generation. The lack of top-line data suggests the company has not yet achieved meaningful sales traction from its flagship products, such as its mobile sizing algorithms or e-commerce integration tools. Margins were not disclosed due to the absence of revenue, making it difficult to assess cost efficiency. The negative EPS surprise of 166.54% highlights a material deviation from Wall Street’s expectations, potentially driven by higher-than-anticipated operating expenditures or one-time charges. Without revenue or segment breakdowns, investors will need to scrutinize the full 10-K filing for a clearer picture of cash burn and operational milestones.
MYSZ Q4 2025 Earnings: EPS Misses Estimates, No Revenue Reported Some traders rely on patterns derived from futures markets to inform equity trades. Futures often provide leading indicators for market direction.Investors who keep detailed records of past trades often gain an edge over those who do not. Reviewing successes and failures allows them to identify patterns in decision-making, understand what strategies work best under certain conditions, and refine their approach over time.MYSZ Q4 2025 Earnings: EPS Misses Estimates, No Revenue Reported Incorporating sentiment analysis complements traditional technical indicators. Social media trends, news sentiment, and forum discussions provide additional layers of insight into market psychology. When combined with real-time pricing data, these indicators can highlight emerging trends before they manifest in broader markets.Some traders combine trend-following strategies with real-time alerts. This hybrid approach allows them to respond quickly while maintaining a disciplined strategy.
Forward Guidance
MYSZ -structural analysis Market participants increasingly appreciate the value of structured visualization. Graphs, heatmaps, and dashboards make it easier to identify trends, correlations, and anomalies in complex datasets. Real-time updates are particularly valuable during periods of high volatility. They allow traders to adjust strategies quickly as new information becomes available. My Size did not provide any formal guidance for fiscal 2026 or update its strategic outlook during the Q4 2025 release. Given the significant earnings miss, management may need to address cost-control measures and prioritize capital preservation. The company could focus on accelerating commercialization efforts, such as licensing its sizing technology to retailers or expanding partnerships, though any revenue growth remains uncertain. Strategic priorities may include reducing cash burn through operational efficiencies while continuing to invest in product development. Risk factors include a limited revenue base, potential need for additional financing, and competitive pressure from alternative sizing solutions. The absence of revenue and the large EPS surprise raise questions about the company’s near-term viability. Investors should watch for any forward-looking statements in subsequent filings or press releases, as well as updates on patent progress or pilot programs. The lack of guidance suggests that management may be reassessing its timeline to market and may adopt a more conservative outlook pending further commercialization milestones.
MYSZ Q4 2025 Earnings: EPS Misses Estimates, No Revenue Reported The interplay between short-term volatility and long-term trends requires careful evaluation. While day-to-day fluctuations may trigger emotional responses, seasoned professionals focus on underlying trends, aligning tactical trades with strategic portfolio objectives.Scenario planning based on historical trends helps investors anticipate potential outcomes. They can prepare contingency plans for varying market conditions.MYSZ Q4 2025 Earnings: EPS Misses Estimates, No Revenue Reported Real-time data can reveal early signals in volatile markets. Quick action may yield better outcomes, particularly for short-term positions.Predicting market reversals requires a combination of technical insight and economic awareness. Experts often look for confluence between overextended technical indicators, volume spikes, and macroeconomic triggers to anticipate potential trend changes.
Market Reaction
MYSZ -structural analysis Combining global perspectives with local insights provides a more comprehensive understanding. Monitoring developments in multiple regions helps investors anticipate cross-market impacts and potential opportunities. Some investors integrate AI models to support analysis. The human element remains essential for interpreting outputs contextually. Despite the sharp EPS miss and zero revenue reported, MYSZ stock rose 1.03% in after-hours trading, indicating that some investors may have already priced in a weak quarter or are focused on potential future catalysts. Analyst reactions have not yet been published, but the magnitude of the negative surprise could prompt downgrades or price target revisions. The stock’s positive move may reflect covering of short positions or speculation about a turnaround—but with no revenue, the company remains highly speculative. What to watch next: the company’s cash position, any progress on commercial agreements, and whether management provides a timeline for achieving first meaningful revenue. The upcoming annual report (10-K) will be critical for understanding operating burn rate and balance sheet health. Given the lack of top-line growth and the significant EPS deviation, the risk profile for My Size appears elevated. Investors should exercise caution and await clearer signs of revenue generation before reassessing the investment thesis. Disclaimer: This analysis is for informational purposes only and does not constitute investment advice.
MYSZ Q4 2025 Earnings: EPS Misses Estimates, No Revenue Reported Many investors now incorporate global news and macroeconomic indicators into their market analysis. Events affecting energy, metals, or agriculture can influence equities indirectly, making comprehensive awareness critical.Investors often monitor sector rotations to inform allocation decisions. Understanding which sectors are gaining or losing momentum helps optimize portfolios.MYSZ Q4 2025 Earnings: EPS Misses Estimates, No Revenue Reported Scenario planning based on historical trends helps investors anticipate potential outcomes. They can prepare contingency plans for varying market conditions.Analytical platforms increasingly offer customization options. Investors can filter data, set alerts, and create dashboards that align with their strategy and risk appetite.